POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,219 | – | 73,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,541,779 | $18,529,569 | 3.63% |
| Velan Capital Investment Management LP | 494,136 | $3,602,251 | 3.18% |
| BVF INC/IL | 9,177,748 | $66,905,783 | 2.82% |
| JOHNSON & JOHNSON | 1,000,000 | $7,290 | 2.12% |
| Cheyne Capital Management (UK) LLP | 127,090 | $926,486 | 1.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,944,760 | 1.49% |
| PFM Health Sciences, LP | 4,633,802 | $33,780,417 | 1.21% |
| Boxer Capital, LLC | 2,500,000 | $18,225,000 | 0.96% |
| Affinity Asset Advisors, LLC | 303,218 | $2,210,459 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 400,812 | $2,921,919 | 0.84% |